...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Orally active PDE4 inhibitors with therapeutic potential.
【24h】

Orally active PDE4 inhibitors with therapeutic potential.

机译:具有治疗潜力的口服活性PDE4抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Based on the successful results in the clinical trial of Ariflo, further optimization of the spatial arrangement of the three pharmacophores (carboxylic acid moiety, nitrile moiety and 3-cyclopentyl-4-methoxyphenyl moiety) in the structure of Ariflo 1 was attempted using a bicyclo[3.3.0]octane template instead of a cyclohexane template. As a result, 2a, 7a and 7b were found to be orally active and were predicted to have an improved therapeutic potential based on evaluation by cross-species and same-species comparisons. Structure-activity relationships (SARs) of these compounds are also discussed.
机译:根据Ariflo临床试验的成功结果,尝试使用双环化合物进一步优化Ariflo 1结构中三个药效团(羧酸部分,腈部分和3-环戊基-4-甲氧基苯基部分)的空间排列用[3.3.0]辛烷模板代替环己烷模板。结果,基于跨物种和同物种比较的评估,发现2a,7a和7b具有口服活性并且被预测具有改善的治疗潜力。还讨论了这些化合物的构效关系(SAR)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号